APOE状态对认知能力下降率的影响
Cassandra Morrison1, Michael D Oliver2,3, Virginia Berry2
1Department of Psychology, Carleton University, Ontario, K1S 5B6, Canada. cassandramorrison@cunet.carleton.ca.
GeroScience
|January 22, 2024
概括
具有主观认知衰退 (SCD) 和至少一个Apolipoprotein (APOE) ɛ4等位基因的个体表现出更快的认知衰退. 这突显了APOE ɛ4作为临床前阿尔茨海默病 (AD) 进展的关键因素.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 老年学是指老年学的学科.
背景情况:
- 主观认知衰退 (SCD) 和Apolipoprotein (APOE) ɛ4阳性是已知的阿尔茨海默病 (AD) 的风险因素.
- 关于SCD和APOE状态之间的相互作用的纵向数据有限.
- 这项研究调查了SCD和轻度认知障碍 (MCI) 患者的APOE基因型和认知轨迹之间的关联.
研究的目的:
- 确定APOE基因型是否会影响SCD患者认知变化速度.
- 评估APOE基因型对MCI患者认知衰退的影响.
- 为了比较SCD和MCI组内的不同APOE基因型的认知变化率.
主要方法:
- 利用了3494名老年人的纵向数据 (1990年正常对照,775名SCD,729名MCI),平均随访时间为9.09年.
- 采用线性混合效应模型来分析APOE状态和认知变化之间的关系.
- 包括来自拉什阿尔茨海默病中心研究分享中心的参与者.
主要成果:
- 与其他所有组相比,患有SCD和至少一个APOE ɛ4等位基因的个体表现出显著增加的认知衰退率.
- 在SCD和MCI组中存在APOE ɛ2等位基因与与APOE ɛ3ɛ3基因型的正常对照相似的认知变化率有关.
- 患有SCD的APOE ɛ4载体比患有MCI或正常对照的APOE ɛ4载体表现出更快的认知衰退.
结论:
- 在具有主观认知衰退的个体中,APOE ɛ4等位基因的存在加快了认知衰退.
- 这些发现强调了APOE ɛ4状态在识别在临床前阶段患AD进展风险较高的个人的重要性.
- 在临床试验和干预中准APOE ɛ4阳性SCD个体可以促进开发有效的阿尔茨海默病治疗方法.
更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.4K
相关概念视频
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:30Cognitive Development During Adulthood
112
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
112
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
126
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
126
01:30Biological Influences on Intelligence
106
Intelligence is often thought to be linked to brain size, but the relationship is more complex than that. While brain size does correlate modestly with some abilities, like verbal skills, the connection is weaker for others, such as spatial reasoning. Other factors, like brain structure, also play crucial roles. For instance, despite Einstein's smaller-than-average brain, his parietal cortex, which is involved in spatial reasoning, was 15% wider, suggesting that neural density might matter...
106
01:28Human Genetics
572
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
572